Skip to main content
SpringerLink
Log in

Oral anticoagulants: will safety be the distinguishing factor?

  • Meeting report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Miller CS, Grandi S, Shimony A, Filion K, Eisenberg M.The Efficacy and Safety of New Oral Anticoagulants versus Warfarin in Patients with Atrial Fibrillation: A Systematic Review and Meta-analysis. 61st Annual Scientific Session of the American College of Cardiology: abstr. 1235-97, 24 Mar 2012. Available from: URL: http://accscientificsession.cardiosource.org/ACC12.aspx

  2. Rajdev A, Bradley J, Petrini J, Alexander J.A Community Experience of the Novel Anticoagulant Pradaxa. 61st Annual Scientific Session of the American College of Cardiology: abstr. 1235-94, 24 Mar 2012. Available from: URL: http://accscientificsession.cardiosource.org/ACC12.aspx

  3. Is Dabigatran safe in 'real life'. 61st Annual Scientific Session of the American College of Cardiology: abstr. 1235-95, 24 Mar 2012. Available from: URL: http://accscientificsession.cardiosource.org/ACC12.aspx

  4. Deitelzweig S, Amin A, Yonghua J, Makenbaeva D, Weiderkehr D, Lin J, Graham J.Comparison of Total Medical Cost Avoidance with the Usage of New Oral Anticoagulants Instead of Warfarin Among Atrial Fibrillation Patients, based on the Aristotle, Re-ly and Rocket-af trials. 61st Annual Scientific Session of the American College of Cardiology: abstr. 1235-92, 24 Mar 2012. Available from: URL: http://accscientificsession.cardiosource.org/ACC12.aspx

  5. Roversi S, malavasi v, D’’Ascenzo F, Abbate A, Castagno D, Van Tassell B, Casali E, Modena MG.Picking the Best Novel Oral Anticoagulant for Atrial Fibrillation: Evidence From a Warfarin-Controlled Network Meta-Analysis. 61st Annual Scientific Session of the American College of Cardiology: abstr. 1235-91, 24 Mar 2012. Available from: URL: http://accscientificsession.cardiosource.org/ACC12.aspx

  6. Baker WL, Phung O.Do Differences Exist Between Oral Anticoagulants in Patients with Nonvalvular Atrial Fibrillation? An Adjusted Indirect Comparison Meta-Analysis. 61st Annual Scientific Session of the American College of Cardiology: abstr. 1235-90, 24 Mar 2012. Available from: URL: http://accscientificsession.cardiosource.org/ACC12.aspx

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Oral anticoagulants: will safety be the distinguishing factor?. React. Wkly. 1403, 3–4 (2012). https://doi.org/10.2165/00128415-201214030-00005

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201214030-00005

Keywords

Search

Navigation